baber/WOPTO huggingface dataset:
Patent NZ-564344-A (NZ)
Title: Mounting structure of exhaust pipe with drain pipe
Inventor: KANEIWA SATOSHI
Filed: 2007-12-14
Abstract: In a mounting structure of an exhaust pipe with a drain pipe that has a horizontal pipe section (131) on an upstream side and a standing pipe section (132) extended upward from the horizontal pipe section, in which the drain pipe (134) extended downward is coupled to the horizontal pipe section in normal phase in which a coupling portion of the drain pipe is located in a lowermost part of a cross section of the horizontal pipe section. A noncircular sectional portion (131a) of a noncircular shape in a cross section is formed in the horizontal pipe section. A fixture (135) attached to the horizontal pipe section in a state in which the fixture is prevented from rotating in the noncircular sectional portion is provided. The fixture is fixed to a body of a burning appliance or a built-in component in the outer case in a state in which the horizontal pipe section is in the normal phase.
Patent NZ-570711-A (NZ)
Title: 2-Substituted-1alpha, 25-dihydroxy-19,26,27-trinor vitamin D analogs and uses thereof
Inventor: DELUCA HECTOR F
IPC: A61K31/59
Filed: 2007-04-06
Abstract: Disclosed are 2-substituted-1a, 25-dihydroxy-19,26,27-trinor vitamin D analogues as represented by the general formula (I), wherein X1, X2 and X3 are independently selected from H and hydroxy protecting groups / prodrugs and R1 and R2 are each methyl. Further disclosed is a pharmaceutical composition which comprises an effective amount of a compound as defined above and a pharmaceutically acceptable carrier for the treatment of a biological condition selected from psoriasis; leukemia; colon cancer; breast cancer; prostate cancer; skin cancer; lung cancer; multiple sclerosis; lupus; diabetes mellitus; host versus graft reaction; rejection of organ transplants; an inflammatory disease selected from rheumatoid arthritis, asthma, and inflammatory bowel diseases; a skin condition selected from wrinkles, lack of adequate skin firmness, lack of adequate dermal hydration, and insufficient sebum secretion; renal osteodystrophy; vitamin D-resistant rickets; osteopenia; osteoporosis; and psostatic arthritis.
Patent NZ-573434-A (NZ)
Title: Use of coumarin derivatives in antifungal therapy
Inventor: STEWART COLIN SAMUEL
IPC: C07D311/18
Filed: 2007-06-05
Abstract: Disclosed is a glycosidic coumarin compound of formula (I), as defined in the specification. The disclosed compound is used in the treatment, prevention or delay of progression of a dermatophytic infection in a patient.
Patent NZ-583665-A (NZ)
Title: Fungicidal mixtures of triticonazole and difenoconazole
Inventor: LINDHOLM DON CRAIG
IPC: A01N43/653
Filed: 2008-09-10
Abstract: Disclosed is a fungicidal mixture comprising triticonazole (formula I) and difenoconazole (formula II). Also disclosed is the fungicidal composition, either solid or liquid containing the two compounds and the method for controlling harmful fungi (especially Phakopsara). Triticonazole is also known as (RS)-(E)-5-(4-chlorobenzylidene)-2,2-dimethyl-1-(1H-1,2,4-triazol-1-ylmethyl)cyclopentanol and difenoconazole is also known as 3-chloro-4-[(2RS,4RS;2RS,4SR)-4-methyl-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-2-yl]phenyl 4-chlorophenyl ether.
Patent NZ-585190-A (NZ)
Title: Engineered dendritic cells and uses for the treatment of cancer
Inventor: BRAUGHLER J MARK
IPC: A61K35/15
Filed: 2008-10-08
Abstract: Disclosed is vector for conditionally expressing a protein having the function of interleukin-12 (lL-12), comprising a polynucleotide encoding a gene switch, said gene switch comprising: (l) at least one transcription factor sequence, wherein said at least one transcription factor sequence encodes a ligand dependent transcription factor, operably linked to a promoter, wherein said promoter is not a stress-inducible promoter, and (2) a polynucleotide encoding said protein having the function of IL-12 linked to a promoter which is activated by said ligand-dependent transcription factor, wherein said polynucleotide encoding said protein having the function of IL-12 encodes a polypeptide at least 85% identical to wild type human IL-12.
Patent NZ-588447-A (NZ)
Title: Apparatus and method for clamping a work piece with a band and a buckle
Inventor: MARELIN MIKLOS BALAZS
IPC: B65B13/02
Filed: 2009-03-12
Abstract: Disclosed is a device (2) for tensioning a band relative to an associated buckle. The band and buckle are positioned around a work piece. The device has a tensioning wheel which engages a first surface of the band and a pinch wheel which engages a second surface of the band. A drive source provides rotational motion to the tensioning wheel. The band that is tensioned and after a predetermined tension is achieved, a mechanism is used to lock the band with respect to the buckle then to cut the band.
Patent NZ-589266-A (NZ)
Title: A retractable cover for the tip of a sharp medical device such as a needle or syringe
Inventor: JONES GARY CHRISTOPHER
IPC: A61M5/50
Filed: 2009-04-23
Abstract: A cover (40) for a tip (42) of a medical device such as a needle (41) is disclosed. The medical device has a body from which there extends an elongated part (41) terminating at said tip (42). The cover includes a cover body (43), and an elongated flexible element (47). The cover body can be mounted on the elongated part (45) for sliding movement along the elongated part, from a retracted position at which the cover body is spaced from the tip (42), to an extended position where the tip (42) is located within and covered by the cover body (43). The elongated flexible element (47) is attached to the cover body (43) and used by an operator so that when tensioning the element the cover body is moved from the retracted position to the extended position where flexible element (47) is released from engagement with said cover body when said tip (42) is located internally of said cover body (43).
Patent NZ-589649-A (NZ)
Title: Arylsulfonylmethyl or arylsulfonamide substituted aromatic compounds suitable for treating disorders that respond to modulation of the dopamine d3 receptor
Inventor: DRESCHER KARLA
IPC: A61K31/13
Filed: 2005-10-14
Abstract: Disclosed are aromatic sulfonyl compounds of formula I, being either arylsulfonylmethyl or arylsulfonamide compounds, and methods for their preparation. The compounds are dopamine D3 receptor ligands. Specific examples of compounds of formula I are: 4-Isopropyl-N-((R)-6-propylamino-5,6,7,8-tetrahydro-naphthalen-2-yl)-benzenesulfonamide, (R)-N-[5-(4-Isopropyl-benzenesulfonylamino)-1,2,3,4-tetrahydro-naphthalen-2-yl]-propionamide, N-((S)-6-Allylamino-5,6,7,8-tetrahydro-naphthalen-2-yl)-4-isopropylbenzenesulfonamide, hydrochloride, and N-[3-(4-Trifluoromethoxy-benzenesulfonylamino)-5,6,7,8-tetrahydro-quinolin-7-yl]-propionamide. Also disclosed is the use of compounds of formula I for treating central nervous system diseases such as addiction.
Patent NZ-591814-A (NZ)
Title: Pesticidal composition comprising an alpha-alkoxyphenyl acetic acid derivative and a neonicotinoid compound
Inventor: TAKAISHI MASANAO
IPC: A01N25/00
Filed: 2009-09-17
Abstract: Disclosed herein is a composition for controlling pests comprising, as active ingredients, an á-alkoxyphenylacetic acid compound represented by formula (1); and a neonicotinoid compound represented by formula (2), wherein the substituents of both compounds are as disclosed in the specification.
Patent NZ-592664-A (NZ)
Title: Communications cable and method of making same
Inventor: WOOSNAM CALVIN H
IPC: H04L69/40
Filed: 2009-10-06
Abstract: Disclosed is an assembly of optical communication fibres. The assembly is comprised of a plurality of buffer tubes (forming part of lines 109), each containing a bundle of silicon-based optical fibres. The buffer tubes together form an assembly of buffer tubes. The assembly of buffer tubes is surrounded by a sheath of dual-layer, opposing direction, bias-woven aramid fibres (layers 200 and 201). An outer jacket (203) also surrounds the sheath of aramid fibres (200, 201).
Patent NZ-594259-A (NZ)
Title: Improved-scent ectoparasiticidal formulation comprising metaflumizone and fructone
Inventor: FATTOHI NAHLA
IPC: A01N37/52
Filed: 2010-02-19
Abstract: Disclosed is an ectoparasiticidal composition comprising metaflumizone ((E,Z)-2-[2-(4-cyanophenyl)-1-[3-(trifluoromethyl)phenyl]ethylidene]-N-[4-(tri-fluoromethoxy)-phenyl]hydrazinecarboxamide) and fructone (ethyl 2-(2-methyl-1,3-dioxolan-2-yl)acetate). The composition is suitable for treating an ectoparasite infestation in warm-blooded animals.
Patent NZ-595078-A (NZ)
Title: Improved type milk-clotting protease derived from a microorganism
Inventor: HARADA KAZUNORI
IPC: C12N15/81
Filed: 2010-03-19
Abstract: Discloses a protease with milk-clotting activity which comprises an amino acid sequence at least 75% identical to SEQ ID NO: 3, said protease has at least one mutation selected from the group consisting of: (A) replacement of glutamine corresponding to glutamine at position 265 in SEQ ID NO: 3 with an acidic amino acid; and (B) replacement of glutamine at position 266 in SEQ ID NO: 3 with an acidic amino acid. Further discloses the said protease with other selected mutations. Further discloses a method for producing a protease with milk-clotting activity comprising the steps of culturing a transformed cell with the disclosed protease sequence in a culture medium and collecting the protease in the culture medium. The disclosed protease finds application in production of cheese and dairy products.
Patent NZ-595612-A (NZ)
Title: Sulphurated derivatives of resorcinol for depigmentation of the skin
Inventor: POIGNY STEPHANE
IPC: A01N31/16
Filed: 2010-04-08
Abstract: The present disclosure relates to analogues of resorcinol sulphide, resorcinol sulphoxide and resorcinol sulphone corresponding to the generic formula (I), wherein the variables are as defined in the specification. These sulphurated derivatives of resorcinol are suitable in cosmetic topical application and are used as an antioxidant active ingredient, as an antibacterial active ingredient, for the depigmentation of the skin, and for the implementation of a method of cosmetic treatment of skin ageing.
Patent NZ-595893-A (NZ)
Title: Securing device and method of use
Inventor: JONES JONATHAN MARTIN
IPC: A41D13/00
Filed: 2011-10-20
Abstract: A securing device 22 configured to be worn by a person, comprises a locking mechanism 26a, 26b that is configured to selectively secure a guard 23 to the securing device 22 at a plurality of positions relative to the securing device 22.
Patent NZ-596197-A (NZ)
Title: Method and apparatus for ultraviolet scan planning
Inventor: KENNY KEVIN B
IPC: G02B21/16
Filed: 2010-05-25
Abstract: A method and an apparatus for locating one or more substantially circular-shaped tissue sample positioned on a solid support are disclosed. The method involves the steps of transmitting light of a preselected wavelength onto a tissue sample, wherein the light induces the tissue sample to autofluoresce, identifying the center location of the tissue sample using the autofluoresced light, correlating the coordinates of the center location of the tissue sample on the solid support using an x, y-coordinate system, and mapping the coordinates of the tissue sample on the solid support to differentiate tissue sample containing regions from blank regions on the solid support. In a second aspect, the invention provides an apparatus for locating one or more substantially circular-shaped tissue sample positioned on a solid support
Patent NZ-599223-A (NZ)
Title: Process to produce stable composition of surfactant and suspending agent with gas level determined by gas bubble test
Inventor: FLECKENSTEIN MELISSA MARIE
IPC: C11D3/22
Filed: 2010-11-04
Abstract: 599223 A process that degasses a structured surfactant composition that comprises at least one surfactant, water, and at least one suspending agent chosen from polysaccharides, gums, and celluloses. By degassing the composition, the suspending agent can form a structured system. Gas, such as air bubbles, disrupts the formation of the structuring system, which reduces the ability of the composition to suspend materials. The process comprises steps of: mixing at least one surfactant, water, and at least one suspending agent chosen from polysaccharides, gums, and celluloses to form a liquid composition; degassing the composition; and measuring an amount of gas in the composition according to the Gas Bubble Test, and continuing steps b) and c) until a desired level of gas is reached.
Patent NZ-601573-A (NZ)
Title: Amine derivative compounds for treating ophthalmic diseases and disorders
Inventor: ORME MARK W
IPC: A61K31/135
Filed: 2008-10-22
Abstract: 601573 Disclosed is a aryl alkylamine or aryl alkoxyamine of formula (A) where the variable are as disclosed in the specification. Examples of compounds of formula (A) are: 4-(3-(3-aminopropoxy)phenylethyl)heptan-4-ol; 4-(3-(3-aminopropoxy)-5-methoxyphenylethyl)heptan-4-ol; 3-(3-(3-aminopropyl)phenyl)-2,2-dimethylpropyl acetate and 1-(3-(3-amino-1-hydroxypropyl)phenyl)hexan-3-ol. Also disclosed is a pharmaceutical composition and the use of a compound of formula (A) in the preparation of a medicament for the treatment of ophthalmic disease or disorder in a subject.
Patent NZ-602835-A (NZ)
Title: Use of at least one intermediate layer disposed in or under a building
Inventor: BURTSCHER PETER
IPC: E04H9/02
Filed: 2011-04-13
Abstract: The use of at least one intermediate layer (2) consisting solely of polyurethane disposed in or under a building (1), the intermediate layer comprising or being made of at least one elastomer for reducing, in particular for preventing, earthquake-related damages to the building.
Patent NZ-609024-A (NZ)
Title: Surgical clamping devices and tools for use therewith
Inventor: WHELAN GEOFFREY PAUL
IPC: A61B17/128
Filed: 2011-10-17
Abstract: Disclosed are surgical clamping devices and applicators for use therewith. The surgical clamping device comprises a body (12) and a pair of clamping members (14, 16) extending from the body. An electronic controller housed within the body is coupled to control movement of at least one of the clamping members to control a pressure exerted by the clamping members on a blood vessel clamped there between. The electronic controller comprises a microcomputer (54), a micro motor (58) and a micro gearbox (62). At least one blood flow sensor (30) is mounted to at least one of the clamping members to detect blood flow in the blood vessel. The clamping members are locked in place when blood flow has been occluded or constricted to the desired extent.
Patent NZ-615512-A (NZ)
Title: Composite wall panel, wall system and components thereof, and a method of construction thereof
Inventor: NEIL PETER MERVYN
IPC: E04B2/86
Filed: 2012-03-16
Abstract: A composite wall, ceiling or floor panel (10), system and method, including a sheet (14) having a first face (18) including at least one first mounting portion (16), and at least one formwork member (24, 26) with at least one second mounting portion (30) arranged to engage with the first mounting portion of the sheet to retain the sheet and said at least one formwork member together. A concrete coating is provided over at least part of the at least one formwork member and at least part of the first face. Structural support comes from piers (for a wall) or beams (ceiling or floor) formed in the spacing between adjacent formwork members. The formwork members act as the core of a wall, ceiling or floor panel. An external coating is applied to the formwork members, such as spray shotcrete or render. Channels (28) formed by the formwork members defines integrated ducting for services to be run.
Patent NZ-624250-A (NZ)
Title: 18f-fluciclovine compositions in citrate buffers
Inventor: ROMOREN KRISTINE
IPC: A61K101/02
Filed: 2012-12-21
Abstract: Disclosed herein are pharmaceutical compositions comprising [18F]1-amino-3-fluorocyclobutane-1-carboxylic acid ([18F]FACBC, commonly known as [18F]-Fluciclovine), and a 50-100 mM citrate buffer and having a pH between 4 and 5 which provides for decreased radiolysis, and not more than 150 µg/mL 1-amino-3-hydroxyl-cyclobutane-1-carboxylic acid (hydroxyl-ACBC). Also disclosed is a method to obtain said pharmaceutical composition.
Patent NZ-630121-A (NZ)
Title: Process for purifying recombinant plasmodium falciparum circumsporozoite protein
Inventor: ALLEN JEFFREY
IPC: C07K14/445
Filed: 2013-04-22
Abstract: The present invention relates to processes for purifying high-quality recombinant Plasmodium falciparum circumsporozoite protein at high yields. This process provides rCSP at high yields without the need for denaturing and refolding the protein. The present invention overcomes obstacles previously encountered in the field, including dimerization, aggregation, and N-terminal degradation of rCSP. The process provided by the invention is scalable, and can be applied to large fermentation batches. The invention also relates to stable liquid formulations of recombinant P. falciparum circumsporozoite protein, and processes for stably maintaining rCSP in a stable liquid formulation.
Patent NZ-630583-A (NZ)
Title: Method for the rapid determination of susceptibility or resistance of bacteria to antibiotics
Inventor: FERNANDEZ GARCIA JOSE LUIS
IPC: C12Q1/18
Filed: 2014-07-02
Abstract: Disclosed is a method of rapidly evaluating the susceptibility of an isolated strain of bacteria to a cell wall synthesis inhibiting antibiotic comprising: a) establishing a bacteria culture from an isolated strain of bacteria; b) combining one or more doses of a cell wall synthesis inhibiting antibiotic with bacteria from the bacteria culture, the concentration of each of the one or more doses being correlated to thresholds of antibiotic resistance for the isolated strain of bacteria to the cell wall synthesis inhibiting antibiotic and at least one of the one or more doses of cell wall synthesis inhibiting antibiotic comprising a determined minimum concentration of the cell wall synthesis inhibiting antibiotic that results in cell enlargement or an increase in cell size in strains of the bacteria that are susceptible to the cell wall synthesis inhibiting antibiotic; c) incubating the bacteria and the one or more antibiotic doses; d) assessing cell length or cell size of incubated bacteria for each of the one or more does of cell wall synthesis inhibiting antibiotic doses; and e) classifying the susceptibility of the isolated strain of bacteria to the cell wall synthesis inhibiting antibiotic based on the cell lengths or cells sizes of bacteria associated with each dose of the one or more doses of cell wall synthesis inhibiting antibiotic.
Patent NZ-710793-A (NZ)
Title: Device for automatic adjustment of the working width of a first plough body in accordance with subsequent plough bodies’ variable working width
Inventor: KRAGGERUD PER
IPC: F15B11/20
Filed: 2014-06-11
Abstract: A device for automatically adjusting the working width of the first plough body (111) of a plough (1) in accordance with the variable working width of subsequent plough bodies (112, 113), in which a first hydraulic cylinder (13) is arranged to displace a rear frame section (117) laterally relative to a front frame section (116), and a second hydraulic cylinder (14) is arranged to pivot the rear frame section (117) around a first vertical pivoting axis (119) in order thereby to adjust a transverse spacing of the plough bodies (111, 112, 113) by the plough bodies (111, 112, 113) pivoting around second vertical pivoting axes (115), wherein the first hydraulic cylinder (13) is a multi-stage cylinder in which a first cylinder stage (131) forms a main lateral control, and a second cylinder stage (132) forms an automatic working-width control for the first plough body (111), the second cylinder stage (132) being in hydraulic-fluid communication with the second hydraulic cylinder (14) in a master-slave configuration, the second cylinder stage (132) being the master or the slave depending on the moving direction of the cylinder stage (132) and the second hydraulic cylinder (14) correspondingly being the slave or the master, and the piston diameters (D1a, D2) of the second cylinder stage (132) and the second hydraulic cylinder (14) being matched to each other so that an adjustment of the working width of the plough bodies (111, 112, 113) by the second hydraulic cylinder (14) provides a correction of the lateral displacement of the front frame section (116). The device makes the working-width adjustment less complicated compared to prior art devices.
Patent NZ-726772-A (NZ)
Title: Dry powder inhaler and inhalation actuated mechanism thereof
Inventor: TAMPIERI VALERIO
IPC: A61M15/00
Filed: 2015-06-19
Abstract: A flap (20) for an inhalation actuated mechanism (18) of a powder inhaler (1) comprises a base member (29), a skirt structure (24) projecting from a surface of the base member (29), and a coupling portion (21) to be coupled to a resilient member (40’) of the inhalation actuated mechanism (18). The skirt structure includes first side wall portions, which substantially extend in a longitudinal direction of the base member, and a second side wall portion which extends between the first side wall portions in a width direction of the base member such that the skirt structure comprising the first side wall portions and the second side wall portion extends along the circumference of the base member, but is open toward a front end of the base member. The skirt structure projects upward from the plate-shaped flat portion of the base member. The coupling portion projects from a lower surface of the base member downward.